Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture. As the numbers of poorly soluble and complex molecules, such ...

Outsourcing drug development is a growing trend in the pharmaceutical and biotechnology industries. With growing pressure to take potential drugs candidates from discovery to human clinical trials as ...

Drug formulation is a cornerstone of modern medicine, turning raw active ingredients into consumable, effective therapies. This critical phase in drug development ensures that medications are safe, ...

For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective, stable, and patient-friendly medications. For the pharmaceutical industry ...

Microemulsions (μEs) are more effective than conventional formulations for ophthalmic use due to their optical transparency, thermodynamic stability, structural flexibility and higher bioavailability.

Monoclonal antibodies (MAbs) are at the focal point of biologics development. Many of the best-selling drugs are therapeutic MAbs or related proteins (1–2). The combined world-wide sales from MAbs ...

At the Centre for Formulation Engineering we are developing solutions to problems facing industries in the pharmaceutical, biotechnological, food, fast moving consumer goods and speciality products ...

Formulation 4.1 continues the story of bringing digital to all aspect of formulation and looks at how Industry 4.0 is changing the formulation industry. The meeting will showcase ongoing activities ...